Lisa Polin
About
In The Last Decade
Lisa Polin
19 papers receiving 386 citations
Peers
Comparison fields: 5 of 70
- Molecular Biology 234
- Oncology 111
- Organic Chemistry 100
- Pharmacology 48
- Cell Biology 42
Countries citing papers authored by Lisa Polin
This map shows the geographic impact of Lisa Polin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa Polin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa Polin more than expected).
Fields of papers citing papers by Lisa Polin
This network shows the impact of papers produced by Lisa Polin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa Polin. The network helps show where Lisa Polin may publish in the future.
Co-authorship network of co-authors of Lisa Polin
This figure shows the co-authorship network connecting the top 25 collaborators of Lisa Polin. A scholar is included among the top collaborators of Lisa Polin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa Polin. Lisa Polin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 38 | |
| 3 | 20 | |
| 4 | 1 | |
| 5 | 25 | |
| 6 | 16 | |
| 7 | 24 | |
| 8 | 6 | |
| 9 | 6 | |
| 10 | 50 | |
| 11 | 41 | |
| 12 | 39 | |
| 13 | Preclinical anticancer activity of cryptophycin-8. | 25 |
| 14 | 9 | |
| 15 | Antitumor efficacy of interleukin-2 alone and in combination with adriamycin and dacarbazine in murine solid tumor systems. | 18 |
| 16 | Antitumor efficacy of PD115934 (NSC 366140) against solid tumors of mice. | 43 |
| 17 | 6 | |
| 18 | 19 | |
| 19 | 4 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.